MOXIFLOXACIN HYDROCHLORIDE
| Brand name | MOXEZA |
|---|---|
| Active ingredient | MOXIFLOXACIN HYDROCHLORIDE |
| Strength | EQ 0.5% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | SOLUTION/DROPS |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | November 2010 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9114168 | May 2029 | product |
| 8450311 | May 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.